M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 25.03 CNY -1.8% Market Closed
Market Cap: 10.8B CNY
Have any thoughts about
Mayinglong Pharmaceutical Group Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

15.5
Current
16.8
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
15.5
=
Enterprise Value
8.2B CNY
/
EBIT
526.9m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
14.2
2-Years Forward
EV/EBIT
11.8
3-Years Forward
EV/EBIT
10.2

See Also

Discover More